Versican-Derived Matrikines Regulate Batf3–Dendritic Cell Differentiation and Promote T Cell Infiltration in Colorectal Cancer

Extracellular matrix and the myeloid-in-myeloma compartment: balancing tolerogenic and immunogenic inflammation in the myeloma niche

(2017) Fotis Asimakopoulos et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Immunoregulatory roles of versican proteolysis in the myeloma microenvironment

(2016) C. Hope et al.   BLOOD

Immunotherapy for prostate cancer: False promises or true hope?

(2016) Brian T. Rekoske et al.   CANCER

Opportunities for immunotherapy in microsatellite instable colorectal cancer

(2016) Harm Westdorp et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Fine-Tuning Cancer Immunotherapy: Optimizing the Gut Microbiome

(2016) J. M. Pitt et al.   CANCER RESEARCH

IRF8 Transcription Factor Controls Survival and Function of Terminally Differentiated Conventional and Plasmacytoid Dendritic Cells, Respectively

(2016) Dorine Sichien et al.   IMMUNITY

Expansion and Activation of CD103 + Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition

(2016) Hélène Salmon et al.   IMMUNITY

Bioactive extracellular matrix fragments in lung health and disease

(2016) Amit Gaggar et al.   JOURNAL OF CLINICAL INVESTIGATION

The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity

(2016) Damya Laoui et al.   Nature Communications

ADAMTS5 Is a Critical Regulator of Virus-Specific T Cell Immunity

(2016) Meagan McMahon et al.   PLOS BIOLOGY

Innate Immune Recognition of Cancer

(2015) Seng-Ryong Woo et al.   Annual Review of Immunology

Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity

(2015) Stefani Spranger et al.   NATURE

Identification of cDC1- and cDC2-committed DC progenitors reveals early lineage priming at the common DC progenitor stage in the bone marrow

(2015) Andreas Schlitzer et al.   NATURE IMMUNOLOGY

The Next Hurdle in Cancer Immunotherapy: Overcoming the Non–T-Cell–Inflamed Tumor Microenvironment

(2015) Thomas F. Gajewski   SEMINARS IN ONCOLOGY

Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells

(2015) A. R. Sanchez-Paulete et al.   Cancer Discovery

Toll-like Receptor 2 Activation Promotes Tumor Dendritic Cell Dysfunction by Regulating IL-6 and IL-10 Receptor Signaling

(2015) Michael Tang et al.   Cell Reports

Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity

(2015) Leticia Corrales et al.   Cell Reports

Microbiota Modulation of Myeloid Cells in Cancer Therapy

(2015) R. S. Goldszmid et al.   Cancer Immunology Research

TPL2 kinase regulates the inflammatory milieu of the myeloma niche

(2014) C. Hope et al.   BLOOD

Selective and efficient generation of functional Batf3-dependent CD103+ dendritic cells from mouse bone marrow

(2014) C. T. Mayer et al.   BLOOD

Macrophage IL-10 Blocks CD8+ T Cell-Dependent Responses to Chemotherapy by Suppressing IL-12 Expression in Intratumoral Dendritic Cells

(2014) Brian Ruffell et al.   CANCER CELL

Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity

(2014) Miranda L. Broz et al.   CANCER CELL

Regulation of the Immune System by the Resident Intestinal Bacteria

(2014) Nobuhiko Kamada et al.   GASTROENTEROLOGY

The multiple, complex roles of versican and its proteolytic turnover by ADAMTS proteases during embryogenesis

(2014) Sumeda Nandadasa et al.   MATRIX BIOLOGY

Versican and the control of inflammation

(2014) Thomas N. Wight et al.   MATRIX BIOLOGY

Myeloid Progenitor Cells in the Premetastatic Lung Promote Metastases by Inducing Mesenchymal to Epithelial Transition

(2012) D. Gao et al.   CANCER RESEARCH

Inflammation Amplification by Versican: The First Mediator

(2012) Zhenwei Zhang et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

(2012) Suzanne L. Topalian et al.   NEW ENGLAND JOURNAL OF MEDICINE

Versican expression is associated with tumor-infiltrating CD8-positive T cells and infiltration depth in cervical cancer

(2010) Arko Gorter et al.   MODERN PATHOLOGY

The biological role and regulation of versican levels in cancer

(2009) Carmela Ricciardelli et al.   CANCER AND METASTASIS REVIEWS

Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis

(2009) Sunhwa Kim et al.   NATURE

Molecular Basis of Colorectal Cancer

(2009) Sanford D. Markowitz et al.   NEW ENGLAND JOURNAL OF MEDICINE